Skip to main content

Table 1 Numbers of patients fulfilling the inclusion criteria with required information

From: Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Inclusion criteria

N

Adults with ALL in CR1 or CR2 allografted from MSD or UD 10/10 or UD 9/10 from January 2000 to December 2017

10,418

Myeloablative conditioning

8400

Available information

 Immunophenotype B or T and Philadelphia status

5540

 MRD status before transplantation reported

2780